Zusammenfassung
Ungewöhnliche Manifestationen urothelialer Tumoren des oberen Harntraktes, sowie die Einführung einer neuen einheitlichen TNM-Klassifizierung der UICC mit Frühjahr dieses Jahres, haben uns veranlaßt die Daten von 28 Patienten der Jahre 1979–1987 retrospektiv hinsichtlich ihrer Symptomatik, Diagnostik, Therapie sowie möglicher ätiologischer Risikofaktoren und Therapieergebnisse zu analysieren.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Davis BW, Hough AJ, Gardner WA (1987) Renal pelvic carcinoma: Morphologicalcorrelates of metastatic behavior. J Urol 137: 857–861
Geiger J, Fong Q, Fay R (1986) Transitional cell carcinoma of renal pelvis with invasion of renal vein and thrombosis of sub-hepatic inferior vena cava. Urology 28: 52–54
Seppelt U, Kasperk EM (1983) Zur Prognose metastasierender Nierenbeckentumoren. Verhandlb Dtsch Ges Urologie 34: 112–115
Jakse G, Rauschmeier H, Fritsch E, Frommhold H, Marberger H (1986) Akt Urol 17: 68–73
Stambolis C, Doppl W, Pust R, Hocke M, Kracht J (1981) Med Welt 49/81: 2–7
Sternberg CN, Yagoda A, Scher HJ, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) J Urol 133: 403–407
Cordell j L, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-Complexes). J Histochem Cytochem 32 /2: 219–229
Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20
Harker WG, Freiha FS, Shortloffe LD, Meyers FJ, Hannigan JF, Flam MS, Torti FM (1984) Cisplatin, Methotrexate and Vinblastine (CMV) chemotherapy for metastatic transitional cell carcinoma of the urinary tract (TCC). Proc ASCO C-627: 160
Meyers FJ, Palmer JM, Freiha FS, Harker WG, Shortliffe J, Hannigan JF, Mc Whirter S, Torti FM (1985) The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastin: A Northern California oncology group study. J Urol 134: 1118
Sternberg C, Yagoda A, Scher H, Hollander P, Watson RC, Ahmed T (1984) Methotrexate, vinblastine, adriamycin and cisplatin for transitional cell carcinoma of the urothelium. Proc of the Am Soc of Clinical Oncology 4, C-609, 156
Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. World J Urol 3: 110
Sternberg CN, Yagoda A, Scher HI et al. (1985) J Urol 133: 403–407
Jakse G, Fritsch E, Fromhold H (1985) World J Urol 3: 121–125
Torti FM, Bristow MR, Howes AE et al. (1984) AACRAbstract No.708
Sternberg CN, Yagoda A, Scher HI et al. (1985) Proc Am Suc Clin Oncol 4: 105–113
Jakse G, Rauschmeier H, Fritsch E et al. (1986) Akt Urol: 68–73
Logothetis CJ, Samuels ML, Selig DE, Johnson DE, Swanson DA, v. Eschenbach AC (1984) Unresectable urothelial tumors with locally advanced disease ± nodal metastasis: A select population with a high complete remission (CR) rate to CisCA chemotherapy. J Urol 131: 170 A, 265
Schwartz S, Yagoda A, Natale RB, Watson RC, Whitmore WF, Lesser M (1983) Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tumors. J Urol 130: 681–684
Sternberg CN, Scher HI (1987) Advances in the treatment of urothelial tract tumors. Urol Clin North Am 14: 373–387
Yagoda A (1983) Chemotherapy for advanced urothelial cancer. Semin Urol 1: 60–74
Logothetics et al. (1985) J Urol 134: 460
Sternberg et al. (1985) J Urol 133: 403
Troner et al. (1987) J Urol 137: 660
Stoter et al. (1987) J Urol 137: 663
Khandekar et al. (1985). J Clin Oncol 3: 539
Hahn R, Kvols L, Frytak S, Nochols W (1984) Phase II Trial of combination VP-16 and Cisplatinum in advanced measurable bladder cancer. Proc Am Soc Clin Oncol 3: 162
Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortlife CD, Hamigan J, Mcwhirter K, Torti FM (1985) The fate of the bladder in patients with metastatic bladder cancer treated with Cisplatin, Methotrexate and Vinblastine: A Northern California oncology group study. J Urol 134: 1118
Soloway MS, Masters SB, Murphy WM (1980) Cisplatin analogs and combination chemotherapy in the therapy of murine bladder cancer. In: Cisplatin - Current status and new developments. Academic, New York, London, Toronto, Sydney, San Francisco, p 345
Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geber N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) Preliminary results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133: 403
Sternberg CN, Yagoda A, Scher HI, Watson RC, Hollander PS, Herr HW, Sogani PC, Morse MJ, Fair WR, Whitmore WF (1985) M-VAC: Update of Methotrexate (MTX), Vinblastine (VLB), Adriamycin (ADM) and Cisplatin ( DDP) for urothelial tract cancer. Proc Am Soc Clin Oncol 4: 105
Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Watson RC, Hollander PS, Morse MJ, Herr HW, Sogani PC, Fair WR (1986) Surgical staging and long term survival in patients with advanced transitional cell carcinoma ( TCC) of the urothelium treated with M-VAC. Proc Am Soc Clin Oncol 5: 101
Stoter G, Splinter TA, Child JA, Fossa SD, Denis L, van Oosterom AT, de Pauw M, Sylvester R for EORTC (1987) Combination Chemotherapy with Cisplatin and Methotrexate in advanced transitional cell cancer of the bladder. J Urol 137: 663
Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. World J Urol 3: 110
Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GMM, Mantell BS, Oliver RTD, Paris AMI, Risdon RA (1980) Br J Urol 52: 506
Bloom HJG, Hendry WF, Wallace DM, Keet RG (1982) Br J Urol 54: 136
Glashan RW, Houghton AL, Robinson MRG (1977) Br J Urol 49: 669
Jakse G, Frommhold H, Marberger H (1983) J Urol 129: 502
Jewett JH (1970) Sixth National Cancer Conference Proceedings, Philadelphia: 211
Wallace DM, Bloom HJG (1976) Br J Urol 48: 587
Oehr P, Adolphs H-D (1987) Urogenitaltumor. In: Lüthgens M, Schlegel G (Hrsg) Tumormarkersystem CEA-TPA. Tumordiagnostik, Leonberg, pp 153–171
Becht E et al. (1985) Exp Urol, Berlin 409
Ohoka et al. (1985) Urol Res 13: 47
Coon et al. (1982) Am J Clin Pat 77: 629
Lipton et al. (1979) Cancer 43: 1766
Osieka R, Schmidt CG (1985) Allgemeine Chemotherapie. In: Gross R, Schmidt CG (Hrsg) Klinische Onkologie. pp 18.1–18. 73
Sternberg CN et al. (1985) Preliminary results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133: 403–407
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Petritsch, P.H. et al. (1988). Postersitzung 1: Das fortgeschrittene Urothelkarzinom. In: Ackermann, R. (eds) Tagung 14.–17. Oktober 1987, Stuttgart. Verhandlungsbericht der Deutschen Gesellschaft für Urologie, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83404-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-83404-2_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19042-4
Online ISBN: 978-3-642-83404-2
eBook Packages: Springer Book Archive